Protective effects of grape seed proanthocyanidins against oxidative stress induced by lipopolysaccharides periodontopathogens

Journal of Periodontology

Volumn 77, Issue 8, 2006, Pages 1371-1379

  Houde, Vanessa ^a   Grenier, Daniel ^a   Chandad, Fatiha ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Nitric oxide; Nitric oxide synthase; Periodontitis; Polyphenols; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; BACTERIUM LIPOPOLYSACCHARIDE; EPIGALLOCATECHIN GALLATE; GALLIC ACID; GRAPE SEED EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PLANT EXTRACT; POLYPHENOL; PROANTHOCYANIDIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SCAVENGER; UNCLASSIFIED DRUG; ENZYME INHIBITOR; FLAVONOID; LIPOPOLYSACCHARIDE; PHENOL DERIVATIVE; POLYPHENOLS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOFLUOROMETRY; DRUG POTENCY; FUSOBACTERIUM NUCLEATUM; GRAPE; HOST PATHOGEN INTERACTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PERIODONTAL DISEASE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCAVENGING SYSTEM; ANIMAL; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; MACROPHAGE; OXIDATIVE STRESS; PLANT SEED;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMALS; ANTIOXIDANTS; CELL LINE; ENZYME INHIBITORS; FLAVONOIDS; FUSOBACTERIUM NUCLEATUM; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PHENOLS; PLANT EXTRACTS; PROANTHOCYANIDINS; REACTIVE OXYGEN SPECIES; SEEDS; VITIS;

EID: 33748565348     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050419     Document Type: Article

References (54)

1. Kinane DF. Causation and pathogenesis of periodontal disease. Periodontol 2000 2001;25:8-20.
2. Nishihara T, Koseki T. Microbial etiology of periodontitis. Periodontol 2000 2004;36:14-26.
3. Dixon DR, Bainbridge BW, Darveau RP. Modulation of the innate immune response within the periodontium. Periodontol 2000 2004;35:53-74.
4. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta 2004;343:1-16.
5. Sheikhi M, Gustafsson A, Jarstrand C. Cytokine, elastase and oxygen radical release by Fusobacterium nucleatum-activated leukocytes: A possible pathogenic factor in periodontitis. J Clin Periodontol 2000; 27:758-762.
6. Knight JA. Review: Free radicals, antioxidants, and the immune system. Ann Clin Lab Sci 2000;30:145-158.
7. Katsuragi H, Ohtake M, Kurasawa I, Saito K. Intracellular production and extracellular release of oxygen radicals by PMNs and oxidative stress on PMNs during phagocytosis of periodontopathic bacteria. Odontology 2003;91:13-18.
8. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-13728.
9. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
10. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994;234: 279-293.
11. Sies H. Oxidative stress: Introductory remarks. In Sies H, ed. Oxidative Stress. London: Academic Press; 1985:1-8.
12. Tsai CC, Chen HS, Chen SL, et al. Lipid peroxidation: A possible role in the induction and progression of chronic periodontitis. J Periodontal Res 2005;40: 378-384.
13. Waddington RJ, Moseley R, Embery G. Reactive oxygen species: A potential role in the pathogenesis of periodontal diseases. Oral Dis 2000;6:138-151.
14. Battino M, Bullon P, Wilson M, Newman H. Oxidative injury and inflammatory periodontal diseases: The challenge of anti-oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med 1999;10:458-476.
15. Canakci CF, Cicek Y, Canakci V. Reactive oxygen species and human inflammatory periodontal diseases. Biochemistry (Mosc) 2005;70:619-628.
16. Batista AC, Silva TA, Chun JH, Lara VS. Nitric oxide synthesis and severity of human periodontal disease. Oral Dis 2002;8:254-260.
17. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 1994;344:721-724.
18. Watanabe N, Miura S, Zeki S, Ishii H. Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide. Free Radic Biol Med 2001;30:1019-1028.
19. Singh D, Lippman S. Cancer chemoprevention part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents. Oncology 1998;12:1787-1800.
20. Hong W, Sporn M. Recent advances in chemoprevention of cancer. Science 1997;278:1073-1077.
21. Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993;20:21-29.
22. Santos-Buelga C, Scalbert A. Proanthocyanidins and tannin-like compounds in human nutrition. J Food Sci Agric 2000;80:1094-1117.
23. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 1995; 235:207-219.
24. Hayek T, Fuhrman B, Vaya J, et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 1997;17: 2744-2752.
25. Zhao J, Wang J, Chen Y, Agarwal R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 1999;20:1737-1745.
26. Maffei-Facino R, Carini M, Aldini G, et al. Procyanidines from Vitis vinifera seeds protect rabbit heart from ischemia/reperfusion injury: Antioxidant intervention and/or iron and copper sequestering ability. Planta Med 1996;62:495-502.
27. Belguendouz L, Fremont L, Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 1997;53:1347-1355.
28. Plumb GW, De Pascual-Teresa S, Santos-Buelga C, Cheynier V, Williamson G. Antioxidant properties of catechins and proanthocyanidins: Effect of polymerisation, galloylation and glycosylation. Free Radic Res 1998;29:351-358.
29. MacCarrone M, Lorenzon T, Guerrieri P, Agro AF. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 1999;265:27-34.
30. Kim HP, Lee JY, Jeong JK, et al. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun 1999;263: 257-262.
31. Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br J Pharmacol 1999;126:673-680.
32. Bagchi D, Garg A, Krohn RL, et al. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 1997;95:179-189.
33. Bagchi D, Garg A, Krohn RL, et al. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 1998; 30:771-776.
34. Darveau RP, Hancock REW. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 1983;155: 831-838.
35. Re R, Pellegrini N, Proteggente A, et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999;26: 1231-1237.
36. 2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol 1998; 110:966-971.
37. Lindhe J, Berglundh T, Ericsson I, Liljenberg B, Marinello C. Experimental breakdown of peri-implant and periodontal tissues: A study in the beagle dog. Clin Oral Implants Res 1992;3:9-16.
38. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004;35:21-41.
39. Preshaw PM, Seymour RA, Heasman PA. Current concepts in periodontal pathogenesis. Dent Update 2004;31:570-572, 574-578.
40. Zappa UE, Polson AM, Espeland MA. Correlations between periodontal tissue breakdown and cell populations. Schweiz Monatsschr Zahnmed 1991;101: 1279-1285.
41. Taylor PR, Martinez-Pomares L, Stacey M, et al. Macrophage receptors and immune recognition. Annu Rev Immunol 2005;23:901-944.
42. Takahashi K. Microbiological, pathological, inflammatory, immunological and molecular biological aspects of periradicular disease. Int Endod J 1998;31: 311-325.
43. Ariga T. The antioxidative function, preventive action on disease and utilization of proanthocyanidins. Biofactors 2004;21:197-201.
44. Bagchi D, Sen CK, Ray SD, et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003;523-524:87-97.
45. Bagchi D, Bagchi M, Stohs SJ, et al. Free radicals and grape seed proanthocyanidin extract: Importance in human health and disease prevention. Toxicology 2000;148:187-197.
46. Akaike T, Suga M, Maeda H. Free radicals in viral pathogenesis: Molecular mechanisms involving superoxide and NO. Proc Soc Exp Biol Med 1998;217: 64-73.
47. Sawa T, Nakao M, Akaike T, Ono K, Maeda H. Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: Implications for the anti-tumor-promoter effect of vegetables. J Agric Food Chem 1999;47:397-402.
48. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 1998;63:854-865.
49. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-350.
50. Kleemann R, Rothe H, Kolb-Bachofen V, et al. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett 1993;328:9-12.
51. Kim OK, Murakami A, Nakamura Y, Ohigashi H. Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 264.7 cells. Cancer Lett 1998;125:199-207.
52. Lin YL, Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol 1997;52:465-472.
53. Comhair SA, Erzurum SC. Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 2002;283:L246-L255.
54. Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999;222:236-245.